The Latest Regenerative Medicine Articles from Streetwise Reports


Regenerative Medicine Firm Reports Positive Chronic Lower Back Pain Trial Results

Research Report
  ()
New study data and next steps for Mesoblast's MPC-06-ID are presented in a Dawson James Securities report. read more >

Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy

Research Report
  ()
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report. read more >

Organogenesis Shares Rise 20% on Q3 Net Revenue Growth and FY Guidance

  ()
Shares of Organogenesis Holdings traded higher after the company reported preliminary Q3/20 financial results demonstrating a 55% increase in year-over-year revenue. read more >

Phase 3 COVID-19 Study of Firm's Stem Cell Product Exceeds 50% Enrollment

Research Report
  ()
The study design and goals and Mesoblast's next steps are reviewed in a Dawson James Securities report. read more >
Showing Results: 1 to 4 of 4

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe